Cargando…
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets
BACKGROUND: The effectiveness of current therapeutic regimens for Mycobacterium tuberculosis (Mtb) is diminished by the need for prolonged therapy and the rise of drug resistant/tolerant strains. This global health threat, despite decades of basic research and a wealth of legacy knowledge, is due to...
Autores principales: | Vashisht, Rohit, Bhat, Ashwini G, Kushwaha, Shreeram, Bhardwaj, Anshu, Consortium, OSDD, Brahmachari, Samir K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201925/ https://www.ncbi.nlm.nih.gov/pubmed/25304862 http://dx.doi.org/10.1186/s12967-014-0263-5 |
Ejemplares similares
-
Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
por: Vashisht, Rohit, et al.
Publicado: (2015) -
Structural Annotation of Mycobacterium tuberculosis Proteome
por: Anand, Praveen, et al.
Publicado: (2011) -
Data Intensive Genome Level Analysis for Identifying Novel, Non-Toxic Drug Targets for Multi Drug Resistant Mycobacterium tuberculosis
por: Kaur, Divneet, et al.
Publicado: (2017) -
Erratum: Data Intensive Genome Level Analysis for Identifying Novel, Non-Toxic Drug Targets for Multi Drug Resistant Mycobacterium tuberculosis
por: Kaur, Divneet, et al.
Publicado: (2017) -
Enhanced ranking of PknB Inhibitors using data fusion methods
por: Seal, Abhik, et al.
Publicado: (2013)